Arrowhead Pharmaceuticals (GB:0HI3)
LSE:0HI3
Holding GB:0HI3?
Track your performance easily

Arrowhead Pharmaceuticals (0HI3) Financial Statements

0 Followers

Arrowhead Pharmaceuticals Financial Overview

Arrowhead Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.65; its P/E ratio is -5.03; Arrowhead Pharmaceuticals is scheduled to report earnings on November 25, 2024, and the estimated EPS forecast is $-0.94. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 3.55M$ 16.10M$ 15.82M
Gross Profit--$ 3.55M$ 16.10M$ 15.82M
EBIT$ -168.88M$ -119.75M$ -133.32M$ -100.88M$ -98.22M
EBITDA$ -164.10M$ -115.23M$ -129.06M$ -97.02M$ -94.95M
Net Income Common Stockholders$ -165.70M$ -125.30M$ -132.86M$ -109.68M$ -102.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 367.27M$ 395.41M$ 162.06M$ 292.74M$ 451.70M
Total Assets$ 883.76M$ 955.15M$ 626.29M$ 765.55M$ 795.86M
Total Debt$ 118.09M$ 118.92M$ 118.58M$ 115.17M$ 82.73M
Net Debt$ -249.18M$ -276.49M$ -43.49M$ -177.56M$ -368.97M
Total Liabilities$ 544.78M$ 459.75M$ 452.57M$ 478.39M$ 413.87M
Stockholders Equity$ 330.55M$ 483.79M$ 160.41M$ 271.34M$ 364.83M
Cash Flow-
Free Cash Flow$ -129.87M$ -126.45M$ -186.50M$ -89.16M$ -68.05M
Operating Cash Flow$ -115.42M$ -92.38M$ -117.84M$ -25.26M$ -21.45M
Investing Cash Flow$ 6.95M$ -268.94M$ 64.84M$ 30.51M$ -9.90M
Financing Cash Flow$ 50.39M$ 430.78M$ 267.00K$ 152.00K$ 1.80M
Currency in USD

Arrowhead Pharmaceuticals Earnings and Revenue History

Arrowhead Pharmaceuticals Debt to Assets

Arrowhead Pharmaceuticals Cash Flow

Arrowhead Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis